ArticleExpert review of ophthalmology2012

Comparisons of actin filament disruptors and Rho kinase inhibitors as potential antiglaucoma medications.

Baohe Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.